Target intelligence / Profile preview

Novel transcript, antisense to TPBGL (ENSG00000308808)

Target
ENSG00000308808
Molecular classification
lncRNA (long non-coding RNA), Family: Other
01

Overview

ENSG00000308808 represents a novel, uncharacterized long non-coding RNA that is transcribed antisense to the TPBGL gene locus. It is not a protein-coding gene and lacks known biological function, disease association, molecular classification beyond "lncRNA," and clinical relevance. None of the available databases assign it a canonical name apart from its generic annotation, and there are no established aliases, functional annotations, or drugs associated with this RNA transcript. Its existence is supported only by genomic prediction and annotation, not by experimental characterization or clinical use[1][4]. In summary, ENSG00000308808 is a provisionally annotated lncRNA, not recognized as a therapeutic target, and currently lacks functional or clinical annotation[1][4].

Other names
GC11M137988TPBGL-AS1
02

Mechanism of action

No mechanisms of action reported; not a target for existing drugs.

03

Biological functions

Unknown
04

Disease associations

None reported

Beyond the preview

Go deeper on Novel transcript, antisense to TPBGL (ENSG00000308808).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to TPBGL (ENSG00000308808).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call